Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning?

被引:28
作者
Burnier, Michel [1 ]
Kreutz, Reinhold [2 ,3 ,4 ]
Narkiewicz, Krzysztof [5 ]
Kjeldsen, Sverre [6 ]
Oparil, Suzanne [7 ]
Mancia, Giuseppe [8 ]
机构
[1] CHU Vaudois, Serv Nephrol & Hypertens, Lausanne, Switzerland
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Humboldt Univ, Freie Univ Berlin, Berlin, Germany
[4] Berlin Inst Hlth, Inst Klin Pharmakol & Toxikol, Berlin, Germany
[5] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland
[6] Univ Oslo, Ullevaal Hosp, Dept Cardiol, Oslo, Norway
[7] Univ Alabama Birmingham, Dept Med, Vasc Biol & Hypertens Programme, Birmingham, AL 35294 USA
[8] Univ Milano Bicocca, Milan, Italy
关键词
bedtime; clinical trials; dipping; drug administration; nocturnal blood pressure; CONVERTING-ENZYME-INHIBITOR; CHRONIC KIDNEY-DISEASE; HYPERTENSIVE PATIENTS; CARDIOVASCULAR RISK; PROGNOSTIC VALUE; GENERAL-POPULATION; SLEEP-APNEA; CARDIORENAL PROTECTION; THERAPEUTIC TARGET; ACTIVE TREATMENT;
D O I
10.1097/HJH.0000000000002532
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Blood pressure (BP) follows a circadian rhythm with a physiological decrease during the night. Studies have demonstrated that nocturnal BP as well as its dipping pattern during night-time have a significant prognostic importance for mortality and the occurrence of cardiovascular events. Therefore, hypertension management guidelines recommend to ascertain that patients treated for hypertension have well controlled BP values around the clock. To improve hypertension control during the night and eventually further reduce cardiovascular events, it has been proposed by some to prescribe at least one antihypertensive medication at bedtime. In this review, we have examined the data which could support the benefits of prescribing BP-lowering drugs at bedtime. Our conclusion is that there is no convincing evidence that the administration of BP-lowering drugs in the evening provides any significant advantage in terms of quality of BP control, prevention of target organ damage or reduction of cardiovascular events. Before changing practice for unproven benefits, it would be wise to wait for the results of the ongoing trials that are addressing this issue.
引用
收藏
页码:1396 / 1406
页数:11
相关论文
共 100 条
[91]   Increased nighttime blood pressure or nondipping profile for prediction of cardiovascular outcomes [J].
Tsioufis, C. ;
Andrikou, I. ;
Thomopoulos, C. ;
Syrseloudis, D. ;
Stergiou, G. ;
Stefanadis, C. .
JOURNAL OF HUMAN HYPERTENSION, 2011, 25 (05) :281-293
[92]   NONINVASIVE AUTOMATIC BLOOD-PRESSURE MONITORING DOES NOT ATTENUATE NIGHTTIME HYPOTENSION - EVIDENCE FROM 24H INTRAARTERIAL BLOOD-PRESSURE MONITORING [J].
VILLANI, A ;
PARATI, G ;
GROPPELLI, A ;
OMBONI, S ;
DIRIENZO, M ;
MANCIA, G .
AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (10) :744-747
[93]   Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories [J].
Vrijens, Bernard ;
Vincze, Gabor ;
Kristanto, Paulus ;
Urquhart, John ;
Burnier, Michel .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7653) :1114-1117
[94]   Evening versus morning dosing regimen drug therapy for chronic kidney disease patients with hypertension in blood pressure patterns: a systematic review and meta-analysis [J].
Wang, Caixia ;
Ye, Yuqiu ;
Liu, Chunyong ;
Zhou, Yongming ;
Lv, Linsheng ;
Cheng, Cailian ;
Li, Shaomin ;
Lou, Tanqi ;
Liu, Xun .
INTERNAL MEDICINE JOURNAL, 2017, 47 (08) :900-906
[95]   Prognostic Effect of Isolated Nocturnal Hypertension in Chinese Patients With Nondialysis Chronic Kidney Disease [J].
Wang, Cheng ;
Li, Yan ;
Zhang, Jun ;
Ye, Zengchun ;
Zhang, Qunzi ;
Ma, Xinxin ;
Peng, Hui ;
Lou, Tanqi .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (10)
[96]   2018 ESC/ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension [J].
Williams, Bryan ;
Mancia, Giuseppe ;
Spiering, Wilko ;
Rosei, Enrico Agabiti ;
Azizi, Michel ;
Burnier, Michel ;
Clement, Denis L. ;
Coca, Antonio ;
de Simone, Giovanni ;
Dominiczak, Anna ;
Kahan, Thomas ;
Mahfoud, Felix ;
Redon, Josep ;
Ruilope, Luis ;
Zanchetti, Alberto ;
Kerins, Mary ;
Kjeldsen, Sverre E. ;
Kreutz, Reinhold ;
Laurent, Stephane ;
Lip, Gregory Y. H. ;
McManus, Richard ;
Narkiewicz, Krzysztof ;
Ruschitzka, Frank ;
Schmieder, Roland E. ;
Shlyakhto, Evgeny ;
Tsioufis, Costas ;
Aboyans, Victor ;
Desormais, Ileana .
JOURNAL OF HYPERTENSION, 2018, 36 (10) :1953-2041
[97]   Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout [J].
Würzner, G ;
Gerster, JC ;
Chiolero, A ;
Maillard, M ;
Fallab-Stubi, CL ;
Brunner, HR ;
Burnier, M .
JOURNAL OF HYPERTENSION, 2001, 19 (10) :1855-1860
[98]  
Yusuf S, 2000, NEW ENGL J MED, V342, P145
[99]   Time of administration important? Morning versus evening dosing of valsartan [J].
Zappe, Dion H. ;
Crikelair, Nora ;
Kandra, Albert ;
Palatini, Paolo .
JOURNAL OF HYPERTENSION, 2015, 33 (02) :385-392
[100]   Evening versus morning dosing regimen drug therapy for hypertension [J].
Zhao, Ping ;
Xu, Ping ;
Wan, Chaomin ;
Wang, Zhengrong .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (10)